Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF

被引:99
|
作者
Mansi, JA
Rivest, S
Drolet, G
机构
[1] UNIV LAVAL, CHUL, UNITE RECH HYPERTENS, LAB NEUROBIOL & HYPERTENS, Ste Foy, PQ G1V 4G2, CANADA
[2] UNIV LAVAL, CHUL, UNITE RECH HYPERTENS, MOL ENDOCRINOL LAB, Ste Foy, PQ G1V 4G2, CANADA
关键词
D O I
10.1210/en.137.11.4619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study sought to examine the effects of intracerebroventricular (icv) administration of corticotropin-releasing factor (CRF) on the expression of CRF, receptor messenger RNA (mRNA) within the hypothalamus as determined by quantitative in situ hybridization histochemistry. Adult male Sprague-Dawley rats were stereotaxically implanted with guide cannulae directed towards the right lateral ventricle. After 8-10 days of recovery, either 10 mu l CRF (5 mu g) or vehicle solution was injected into the lateral ventricle over a 2-min period. The rats were then deeply anesthetized at 15, 60, and 180 min after icv injection, transcardially perfused, and their brains cut into 30-mu m coronal sections. Brain sections were then processed using standard radioactive in situ hybridization histochemistry revealing the expression of the CRF, receptor mRNA. Low to moderate basal levels of CRF, receptor transcript were observed in several regions of the forebrain. However, the hybridization signal for the mRNA encoding the CRF, receptor was barely detectable in the paraventricular nucleus of the hypothalamus (PVN) of vehicle-injected rats. In contrast, 180 min after icv administration of CRF, a significant increase in CRF, receptor transcript was measured specifically in the PVN, despite having virtually any hybridization signal before 180 min. This increase in the level of receptor transcription by CRF was restricted to the type 1 receptor subtype because the hybridization signal for the CRF(2 alpha) receptor mRNA was unaffected in the brain regions in which it was located. Moreover, we confirmed previous findings of a CRF-induced neuronal activation of parvocellular neurosecretory cells of the PVN, as assessed by c-fos mRNA expression. This neuronal activation induced by exogenous CRF was also associated with a rapid and strong induction of CRF heteronuclear RNA selectively in the rat PVN, a phenomenon abolished by a pretreatment with a CRF receptor antagonist. These results provide evidence that elevated levels of central CRF may trigger CRF, receptor transcription selectively in the PVN. This positive feedback of CRF on its own receptor may represent a functional adaptation of the hypothalamic-pituitary-adrenal axis in response to stress.
引用
收藏
页码:4619 / 4629
页数:11
相关论文
共 50 条
  • [21] Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior
    Heinrichs, SC
    Lapsansky, J
    Lovenberg, TW
    DeSouza, EB
    Chalmers, DT
    REGULATORY PEPTIDES, 1997, 71 (01) : 15 - 21
  • [22] Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain
    Brunson, KL
    Grigoriadis, DE
    Lorang, MT
    Baram, TZ
    EXPERIMENTAL NEUROLOGY, 2002, 176 (01) : 75 - 86
  • [23] Urocortin and corticotropin-releasing factor (CRF) receptor type 1 mRNA are expressed in the rat colon.
    Million, M
    Sanchez-Watts, G
    Miampamba, M
    Wang, LX
    Tache, Y
    Watts, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A173 - A173
  • [24] Corticotropin-Releasing Factor (CRF) and Urocortin 1 (UCN1) Differentially Regulate Trafficking and Signaling of Corticotropin-Releasing Factor Receptor 1 (CRF-R1)
    Hasdemir, Burcu
    Liao, Min
    Bunnett, Nigel W.
    Bhargava, Aditi
    GASTROENTEROLOGY, 2010, 138 (05) : S257 - S257
  • [25] RAT HYPOTHALAMUS INVITRO - STIMULATION OF RELEASE OF CORTICOTROPIN-RELEASING FACTOR (CRF) BY NOREPINEPHRINE
    VOIGT, KH
    FEHM, HL
    BRECHT, K
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1979, 379 : R34 - R34
  • [26] Long-term expression of corticotropin-releasing factor (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation
    Greenwood-Van Meerveld, B
    Johnson, AC
    Schulkin, J
    Myers, DA
    BRAIN RESEARCH, 2006, 1071 (01) : 91 - 96
  • [27] IMMUNO-CYTOCHEMICAL LOCALIZATION OF CORTICOTROPIN-RELEASING FACTOR (CRF) IN THE RAT HYPOTHALAMUS
    PELLETIER, G
    DESY, L
    COTE, J
    VAUDRY, H
    LEFEVRE, G
    LABRIE, F
    JOURNAL OF CELL BIOLOGY, 1982, 95 (02): : A179 - A179
  • [28] Selective peripheral activation of corticotropin-releasing factor (CRF) receptor type 1 (CRF1) by cortagine:: A new model of IBS-D-like symptoms in rodents
    Larauche, Muriel H.
    Yuan, Pu-Qing
    Gourcerol, Guillaume
    Wang, Lixin
    Pambukchian, Karina
    Brunnhuber, Stefan
    Adelson, David W.
    Million, Mulugeta
    Rivier, Jean E.
    Tache, Yvette
    GASTROENTEROLOGY, 2008, 134 (04) : A277 - A277
  • [29] V1B/CRF1 receptor heterodimerisation as a key mechanism of vasopressin and corticotropin-releasing factor synergism
    Mion, J.
    Boulay, V.
    Millan, M. J.
    Guillon, G.
    Corbani, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S9 - S10
  • [30] Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists
    Huang, CQ
    Wilcoxen, K
    McCarthy, JR
    Haddach, M
    Webb, TR
    Gu, J
    Xie, YF
    Grigoriadis, DE
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3375 - 3379